Evidence map›Paper›PMID 20672310›Full record

ArticleJournal of cellular biochemistry2010

Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.

Maya Styner, Buer Sen, Zhihui Xie, Natasha Case, Janet Rubin

Abstract read
In one paragraph

Article in Journal of cellular biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Exercise Degrades Bone in Caloric Restriction, Despite Suppression of Marrow Adipose Tissue (MAT).Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maya StynerDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7170, USA. mstyner@med.unc.edu
Buer Sen
Zhihui Xie
Natasha Case
Janet Rubin
University of North Carolina at Chapel Hill · USUniversity of North Carolina Health Care · US

Funding

UNC BIRCWH CAREER DEVELOPMENT PROGRAMK12HD001441 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOGGESS, KIM A · 2000 to 2019
$9.3M
TRAINING PROGRAM IN ENDOCRINOLOGY &METABOLISMT32DK007129 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 1986 to 2009
$2.9M
ELECTRIC FIELD ATTENUATION OF OSTEOCLAST FORMATIONR01AR042360 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 1993 to 2013
$2.8M
Mechanical Control of Mesenchymal Stem Cell Lineage AllocationR01AR056655 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 2010 to 2014
$1.4M
ORGANIZATION OF MECHANICAL SIGNALS VIA MEMBRANE SCAFFOLDR01AR052014 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 2005 to 2008
$1.1M
Biophysical regulation of bone remodelingR56AR042360 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 2008 to 2008
$289k
NIAMS NIH HHS AR042360NIAMS NIH HHS AR52014NIAMS NIH HHS R01 AR042360NIAMS NIH HHS R01 AR052014NIAMS NIH HHS R01 AR056655NIAMS NIH HHS R56 AR042360NICHD NIH HHS K12 HD001441NIDDK NIH HHS DK007129NIDDK NIH HHS T32 DK007129
6 · The paper itself

Abstract

Regulation of mesenchymal stem cell (MSC) lineage selection is important for the generation of bone mass. Inhibition of cyclooxygenase-2 (COX2) may increase adipogenesis at the cost of decreasing osteoprogenitor output. Here we investigated the role of COX2 and its products during MSC differentiation. Indomethacin stimulated adipogenesis (increased aP2, adiponectin and lipid droplets) of CH310T1/2 stem cells as well as marrow-derived MSCs to a degree similar to the PPARγ2 ligand, rosiglitazone. Unlike rosiglitazone, indomethacin significantly upregulated PPARγ2 expression. Indomethacin and the COX2 specific inhibitor celecoxib suppressed PGE2 production, but celecoxib did not induce adipogenesis. As well, addition of PGE2 failed to reverse indomethacin induced adipogenesis, indicating that indomethacin's effects were prostaglandin independent. In MSCs over-expressing PPARγ2 and RXRα, indomethacin did not increase PPAR-induced transcription, while rosiglitazone and 15d-PGJ2 did (1.7- and 1.3-fold, respectively, P < 0.001). We considered whether indomethacin might directly affect C/EBPβ proximally to PPARγ2 induction. Indomethacin significantly increased C/EBPβ expression and protein within 24 h of addition. These results indicate that indomethacin promotes adipogenesis by increasing C/EBPβ and PPARγ2 expression in a prostaglandin-independent fashion. This effect of indomethacin is pertinent to potential deleterious effects of this commonly used anti-inflammatory drug on bone remodeling and tissue healing.

Indexed as

AdipogenesisAnimalsbeta CateninCCAAT-Enhancer-Binding Protein-betaCelecoxibCell LineCyclooxygenase 2DinoprostoneDose-Response Relationship, DrugGene Expression Regulation, EnzymologicIndomethacinLigandsMesenchymal Stem CellsMicePPAR gammaPyrazolesbeta CateninCCAAT-Enhancer-Binding Protein-betaCelecoxibCyclooxygenase 2DinoprostoneIndomethacinLigandsPPAR gammaPtgs2 protein, mousePyrazolesSulfonamides

Identifiers

PMID20672310
PMCPMC3627539
OpenAlexW2025811790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.